Kangpei Announces Board Resolution to Buy Back and Cancel Restricted Employee Share Rights for Capital Reduction
Kangpei announced a board resolution to carry out capital reduction by canceling restricted employee… · 2026-06-26
Kangpei announced a board resolution to carry out capital reduction by canceling restricted employee… · 2026-06-26
Kangpei announced that its board of directors resolved on June 26, 115, to amend certain provisions … · 2026-06-26
Kangpei's board of directors resolved on June 26, 2026, to revise its 2025 Restricted Stock Unit (RS… · 2026-06-26
Kangpei Biotech Co., Ltd. has resolved to issue 23,000 new restricted stock units for its employees … · 2026-06-26
Kangpei has announced that its second global pivotal Phase 3 clinical trial, CBL-0302 (SUPREME-02), … · 2026-06-18
康霈生技 announced on June 3, 2026, the submission of its Phase 3b long-term follow-up clinical trial (C… · 2026-06-03
康霈* announced that its second multi-center Phase 3 clinical trial (CBL-0302) for the new drug CBL-51… · 2026-05-28
Kang-Pei Biotech has been invited to participate in the '2026 Q2 Global Investment Forum' hosted by … · 2026-05-26
KangPai Biotech held its annual general meeting on May 22, 2026, and completed a comprehensive re-el… · 2026-05-22
KangPei held its Annual General Meeting on May 22, 115, approving the 114 fiscal year financial stat… · 2026-05-22
Kang霈 has appointed Lin Ching-Po, Lo Pao-Chu, and Peng Hsien-Li as members of its 3rd Remuneration C… · 2026-05-22
Kangstem Biotech held its 9th Board of Directors meeting on May 22, 2026, to elect a new Chairman fo… · 2026-05-22
Kangpu Biotech announced its 3rd Audit Committee member list on May 22, 2026, due to the expiration … · 2026-05-22
ConMed Biotech held a general shareholder meeting on May 22, 2026, and approved the resolution to wa… · 2026-05-22
Kangpe Biotechnology announced on May 20, 2026, that it has completed the clinical trial application… · 2026-05-20
KangPu has received approval from the Taiwan TFDA for its Phase 2 clinical trial (CBL-0206) for CBL-… · 2026-05-19
Canopy Biosciences announced that its IND application for the second multi-national, multi-center pi… · 2026-05-18
Biotech firm Canpep Inc. announced that its second pivotal Phase 3 clinical trial (CBL-0302) for the… · 2026-05-18
Biotechnology company Caliway Biopharmaceuticals announced its consolidated revenue for May 2026 at … · 2026-05-01
Kangpu announced the completion of its Clinical Trial Application (CTA) to Health Canada for CBL-030… · 2026-04-30
Kangpu announced the completion of its Clinical Trial Application (CTA) to Health Canada for CBL-030… · 2026-04-30
Caliway Biomedical (康霈) announced the completion of its Taiwan TFDA IND application for CBL-514 inje… · 2026-04-28
Caliway Biomedical (康霈) announced the completion of its Taiwan TFDA IND application for CBL-514 inje… · 2026-04-28
Caliway Biopharmaceuticals announced that its new drug CBL-514 injection for subcutaneous fat reduct… · 2026-04-23
Caliway Biopharmaceuticals announced that its new drug CBL-514 injection for subcutaneous fat reduct… · 2026-04-23
Clover Biopharmaceuticals announced that the second pivotal Phase 3 clinical trial (SUPREME-02, code… · 2026-04-20
Clover Biopharmaceuticals announced that the second pivotal Phase 3 clinical trial (SUPREME-02, code… · 2026-04-20
KangPao* has disclosed significant financial and business information as its securities reached the … · 2026-04-09
KangPao* has disclosed significant financial and business information as its securities reached the … · 2026-04-09
KangPao* has disclosed significant financial and business information as its securities reached the … · 2026-04-09
KangHui* (6919), a biotechnology and healthcare company, reported April 2026 revenue of 3.57 million… · 2026-04-01
KangHui* (6919), a biotechnology and healthcare company, reported April 2026 revenue of 3.57 million… · 2026-04-01
Kangpei*, a company in the biotechnology and medical industry, reported a minimal monthly revenue of… · 2026-03-01
Kangpei*, a company in the biotechnology and medical industry, reported a minimal monthly revenue of… · 2026-03-01
Canopy* (6919) has announced its financial report for February 2026. The company's revenue for the m… · 2026-02-01
Canopy* (6919) has announced its financial report for February 2026. The company's revenue for the m… · 2026-02-01